DBO 17
Latest Information Update: 22 May 2001
Price :
$50 *
At a glance
- Originator Nonindustrial source
- Class Analgesics
- Mechanism of Action Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pain
Most Recent Events
- 22 May 2001 No-Development-Reported for Pain in Italy (Unknown route)
- 19 Dec 1997 New profile
- 19 Dec 1997 Preclinical development for Pain in Italy (Unknown route)